Locally Recurrent Breast Cancer After Mastectomy Reconstruction: Surgical Considerations
Mary M. Mrdutt, M.D. 
Assistant Professor of Surgery
 

Clinical Behavior Management and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer
Dan Moldoveanu, M.D. M.Ch.
Breast Surgery Fellow

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Review presentation of locally recurrent breast cancer following mastectomy
• Discuss management options for breast reconstruction in the setting of post-mastectomy local reccurence 
   
• Identify the unique challenges associated with the clinical management of ER-low breast cancer
• Define the role of preserved PR expression in patients with ER-low breast cancer, as well as its implications
• Contrast ER-low (1-10%) breast cancer with ER >10% and with ER negative breast cancer regarding chemotherapy use, endocrine therapy use and treatment response
   

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. Attendance must be manually recorded in MedHub. Contact MSCGME support staff for assistance.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.